Mounjaro can boost weight loss in people without diabetes
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...
ABC News5d
Compound versions of some weight loss drugs to be restricted
In recent months, Eli Lilly, the maker of Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy, have each said that they are able to meet the demand for the medications after ...
pharmaphorum2d
Lilly’s Mounjaro wins latest head-to-head battle in clinical trials of diabetes treatments
Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s Ozempic in clinical trials. For some patients, injectables ...
The Financial Express6d
Popular weight loss drugs Ozempic and Mounjaro hold potential to transform type 1 diabetes treatment: GlobalData
(Image Credits: Pexel) A new study has revealed that off-label use of semaglutide (Ozempic) and tirzepatide (Mounjaro) leads to significant reductions in HbA1c levels and body weight among adults ...
Daily Mail6d
Gemma Collins shows off her incredible figure in an 'unfiltered' photoshoot - after losing two stone on Mounjaro weight loss jab
The TOWIE alum, 44, has been incredibly open about loosing two stone on the Mounjaro weight loss jab after being unable to turn over in bed. Gemma has long struggled with her weight and ...
The Independent3d
Thank God I’ve stopped microdosing Ozempic – this is what it’s really like
Recent figures suggest more than half a million people in the UK are taking Mounjaro or Wegovy (the version of Ozempic approved for weight loss, rather than diabetes control, although private ...
The Indian Express5d
Ekta Kapoor wonders about the best weight loss solution: ‘Ozempic, Mounjaro or anti-inflammatory diet’
“Been in Chennai. I have some time. What do I do? I have gained a lot of weight. Should I do an anti-inflammatory diet, or should I do mounjaro or ozempic? Or all of the above? Or leave it? Hum bade ...
GMA6d
Compound versions of some weight loss drugs to be restricted
In recent months, Eli Lilly, the maker of Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy, have each said that they are able to meet the demand for the medications after ...